72254-94-5 Usage
Derivative of indole
Indole is a heterocyclic aromatic organic compound 1-methyl-2,3-dihydro-indol-5-ol is derived from 1-methyl-2,3-dihydro-indol-5-ol, meaning it has a similar structure with some modifications.
Physical properties
Colorless solid with a faint odor This describes the appearance and smell of 1-methyl-2,3-dihydro-indol-5-ol.
Natural occurrence
Occurs naturally in certain plants and animals 1-methyl-2,3-dihydro-indol-5-ol can be found in some organisms, indicating that it may have biological functions or roles.
Synthesis in pharmaceuticals
Used in the synthesis of various pharmaceuticals 1-methyl-2,3-dihydro-indol-5-ol is a key component in creating different medications, which suggests its importance in drug development.
Potential applications
Field of medicine and drug development Due to its various biological activities, 1-methyl-2,3-dihydro-indol-5-ol has potential uses in medical treatments and the development of new drugs.
Biological activities
Antioxidant, anti-inflammatory, and antimicrobial properties These are some of the key biological activities exhibited by 1-methyl-2,3-dihydro-indol-5-ol, making it a valuable compound for further research and development.
Check Digit Verification of cas no
The CAS Registry Mumber 72254-94-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,2,2,5 and 4 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 72254-94:
(7*7)+(6*2)+(5*2)+(4*5)+(3*4)+(2*9)+(1*4)=125
125 % 10 = 5
So 72254-94-5 is a valid CAS Registry Number.
72254-94-5Relevant academic research and scientific papers
Therapeutic diphenyl ether ligands
-
Page/Page column 35, (2010/10/20)
This invention is directed to compounds of formula Ia, Ib or Ic and to pharmaceutical compositions thereof: or a prodrug thereof and a pharmaceutically acceptable carrier, wherein the R groups are defined in the specification; and, in which the dashed line represents an optional double bond. The invention is also directed to methods of treating, diagnosing, and preventing disorders of the central nervous system that are associated with 5HT receptors, including obesity, attention deficit disorder, migraine, depression, epilepsy, anxiety, Alzheimer's disease, withdrawal from drug abuse, pain, schizophrenia, stress-related disorders, panic disorder, sleep disorders, phobias, obsessive compulsive disorder, post-traumatic-stress syndrome, immune system depression, stress-induced gastrointestinal dysfunction, stress-induced cardiovascular dysfunction, and sexual dysfunction.
